"10.1371_journal.pone.0141378","plos one","2015-10-27T00:00:00Z","Keiko Ikoma-Seki; Kanae Nakamura; Satoru Morishita; Tomoji Ono; Keikichi Sugiyama; Hoyoku Nishino; Hisashi Hirano; Michiaki Murakoshi","Research and Development Headquarters, Lion Corporation, Kanagawa, Japan; Advanced Medical Research Center, Yokohama City University, Kanagawa, Japan; Kyoto Prefectural University of Medicine, Kyoto, Japan; Ritsumeikan University, Shiga, Japan","Conceived and designed the experiments: KI TO HH. Performed the experiments: KI KN TO HH. Analyzed the data: KI HH. Contributed reagents/materials/analysis tools: HH TO MM. Wrote the paper: KI TO MM HH. Obtained advice and discussed about data: KI KT SM TO KS HN HH MM.","K. Ikoma-Seki, K. Nakamura, S. Morishita, T. Ono, and M. Murakoshi are employees of Lion Corporation. H. Nishino and K. Sugiyama received consulting fees from Lion Corporation. This work was supported by Lion Corporation, and the proteomic analysis part was supported by the Establishment of Research Center for Clinical Proteomics of Post-Translational Modifications (a research task of the Creation of “Innovation Centers for Advanced Interdisciplinary Research Areas” program of Project for Developing Innovation Systems of the Ministry of Education, Culture, Sports, Science and, Technology, Japan (ID: 11800122)). This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.","2015","10","Keiko Ikoma-Seki","KIS",8,TRUE,3,4,2,4,TRUE,TRUE,FALSE,0,NA,FALSE
